) obtained regulatory clearance from the U.S. Food & Drug
Administration (FDA) for its ISO-Gard Mask with ClearAir
Technology. This new product will form a part of the anesthesia
and respiratory business unit and will help reduce exposure of
clinicians to dangerous waste anesthetic gases.
In the U.S., almost 20 million surgeries utilize anesthetic
gases. As a result, patients recovering in Post Anesthesia Care
Unit (PACU), breathe out these gases that prove to be harmful for
nurses and the work environment. The ISO-Gard Mask will lessen
the waste anesthetic gas (WAG) providing minimal exposure to the
harmful gases in the PACU. According to the Occupational Safety
and Health Administration (OSHA), WAG exposure can cause
dizziness, fatigue, headache, and nausea.
This un-patented ClearAir technology is multi-purpose, and not
only diminishes the amount of waste air in the hospital
environment but provides oxygen to the patient as well. The
ISO-Gard Mask with ClearAir technology will expand the Telefelx
line of Hudson RCI respiratory products.
Teleflex is a global leader in medical devices used in critical
care and surgery. The company focuses on profitable and
consistent growth and expects its sales growth to surpass market
growth in the long run. It also plans to gain market share in key
product areas. Teleflex operates in a highly competitive medical
devices industry and stringent regulatory environment. The demand
for its products is susceptible to healthcare reimbursement
systems in the domestic as well as the international market.
Currently, Teleflex carries a Zacks Rank #2 (Buy). Other
medical instrument stocks worth considering are
Given Imaging Ltd.
), all of which carry a Zacks rank #1 (Strong Buy).
CEPHEID INC (CPHD): Free Stock Analysis
CYBERONICS INC (CYBX): Free Stock Analysis
GIVEN IMAGING (GIVN): Free Stock Analysis
TELEFLEX INC (TFX): Free Stock Analysis
To read this article on Zacks.com click here.